Skip to main content
SpringerLink
Log in

Respiratory syncytial virus: Virology, diagnosis, and vaccination

  • Viral Bronchiolitis In Infancy
  • Published:
Lung Aims and scope Submit manuscript

Abstract

Attempts to develop a respiratory syncytial virus vaccine have revealed the antigenic heterogeneity of the virus and have highlighted the difficulties of inducing protective responses in very young infants. Of the two subgroups of the virus, A and B, that cocirculate, A appears to be the most aggressive in infants, but protection against both will be required. Although a degree of protection is transferred from mother to the infant via the placenta and by breast feeding, the mechanisms of protection remain illunderstood and early hopes of exploiting this phenomenon have not been realized. The immune response to the virus in the very young is depressed but disease severity is not demonstrably linked to failure to control virus replication. Rather, immune mechanisms contribute directly to the development of bronchiolitis. The involvement of the immune response in the pathologic process increases the hazards of vaccination. Research is currently focused on the definition of viral epitopes necessary to induce only a protective immune response and their incorporation into a suitable vaccine vector.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. McIntosh K, Chanock RM (1985) Respiratory syncytial virus. In: Fields BN (ed) Virology. Raven Press, New York, pp 1285–1304

    Google Scholar 

  2. Klein BS, Dollete FR, Yoken RH (1982) The role of respiratory syncytial virus and other viral pathogens in acute otitis media. J Pediat 102:16–20

    Article  Google Scholar 

  3. Norrby E, Mufson MA, Sheshbaraderan H (1986) Structural differences between subtype A and B strains of respiratory syncytial virus. J Gen Virol 67:2721–2729

    Article  PubMed  CAS  Google Scholar 

  4. Johnson PR, Spriggs MK, Olmsted RA, Collins PL (1987) The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: Extensive sequence divergence between antigenically related proteins. Proc Natl Acad Sci USA 84:5625–5629

    Article  PubMed  CAS  Google Scholar 

  5. Taylor CE, Morrow S, Scott M, Young B, Toms GL (1989) Comparative virulence of respiratory syncytial virus subgroups A and B. Lancet 1:777

    Article  PubMed  CAS  Google Scholar 

  6. Prince GA, Horswood RL, Koenig DW, Chanock RM (1985) Antigenic analysis of a putative new strain of respiratory syncytial virus. J Infect Dis 151:634–637

    PubMed  CAS  Google Scholar 

  7. Bangham CRM, Askonas BA (1986) Murine cytotoxic T cells specific to respiratory syncytial virus recognize different antigenic subtypes of the virus. J Gen Virol 67:623–629

    Article  PubMed  CAS  Google Scholar 

  8. Murphy BR, Prince GA, Walsh EE, Kim HW, Parrot RH, Hemming VG, Rodriguez WJ, Chanock RM (1986) Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine. J Clin Microbiol 24:197–202

    PubMed  CAS  Google Scholar 

  9. Stott EJ, Taylor G (1985) Respiratory syncytial virus. Arch Virol 84:1–52

    Article  PubMed  CAS  Google Scholar 

  10. Stott EJ, Taylor G, Ball LA, Anderson K, Young KKY, King AMQ, Wertz GW (1987) Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus. J Virol 61:3855–3861

    PubMed  CAS  Google Scholar 

  11. Taylor G, Stott EJ, Bew M, Fernie BF, Cote PJ, Collins AP, Hughes M, Jebbett, J (1984) Monoclonal antibodies protect against respiratory syncytial virus infection in mice. Immunology 52:137–142

    PubMed  CAS  Google Scholar 

  12. Routledge EG, Willcocks MM, Samson ACR, Morgan L, Scott R, Toms GL (1988) The purification of four respiratory syncytial virus proteins and their evaluation as protective agents against experimental infection in BALB/c mice. J Gen Virol 69:293–303

    Article  PubMed  CAS  Google Scholar 

  13. Samson ACR, Willcocks MM, Routledge EG, Morgan LA, Toms GL A neutralising monoclonal antibody to respiratory syncytial virus which binds to both F1 and F2 components of the fusion protein.

  14. Trudel M, Nadon F, Seguin C, Dionne G, Lacroix M (1987) Identification of a synthetic peptide as part of a major neutralization epitope of respiratory syncytial virus. J Gen Virol 68:2273–2280

    Article  PubMed  CAS  Google Scholar 

  15. Norrby E, Mufson MA, Alexander H, Houghten RA, Lerner RA (1987) Site-directed serology with synthetic peptides representing the large glycoprotein G of respiratory syncytial virus. Proc Natl Acad Sci USA 84:6572–6576

    Article  PubMed  CAS  Google Scholar 

  16. Nandapalan N, Taylor CE, Greenwell J, Scott M, Scott R, Hey EN, Toms GL (1986) Seasonal variations in maternal serum and mammary immunity to RS virus. J Med Virol 20:79–87

    Article  PubMed  CAS  Google Scholar 

  17. Nandapalan N, Taylor C, Scoot R, Toms GL (1987) Mammary immunity in mothers of infants with respiratory syncytial virus infection. J Med Virol 22:277–287

    Article  PubMed  CAS  Google Scholar 

  18. Hemming VG, Rodriguez W, Kim HW, Brandt CD, Parrot RH, Burch B, Prince GA, Baron PA, Fink RJ, Reaman G (1987) Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children. Antimicrob Agents Chemother 31:1882–1886

    PubMed  CAS  Google Scholar 

  19. Cannon MJ, Openshaw PJM, Askonas BA (1988) Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J. Exp. Med. 168:1163–1168

    Article  PubMed  CAS  Google Scholar 

  20. Openshaw PJM, Wertz GW (1989) Differential induction of immunopathological effects in the lungs after intranasal challenge with respiratory syncytial virus (RSV) in mice primed with vaccinia recombinants expressing single RSV proteins (Abstract 105-28). In: Proceedings of the 7th International Congress of Immunology 1989. Gustav Fischer Verlag Stuttgart, New York, p. 743

    Google Scholar 

  21. Toms GL, Webb MSC, Milner PD, Milner AD, Routledge EG, Scott R, Stokes GM, Swarbrick A, Taylor CE (1989) Immunoglobulin G and M antibodies to viral glycoproteins in respiratory syncytial virus infections of graded severity. Arch Dis Child 64:1661–1665

    Article  PubMed  CAS  Google Scholar 

  22. Taylor CE, Webb MSC, Milner AD, Milner PD, Morgan LA, Scott R, Stokes GM, Swarbrick AS, Toms GL (1989) Interferon alpha, infectious virus and virus antigen secretion in respiratory syncytial virus infections of graded severity. Arch Dis Child 64:1656–1660

    Article  PubMed  CAS  Google Scholar 

  23. Isaacs D, Bangham CRM, McMichael AJ (1987) Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis. Lancet 2:769–771

    Article  PubMed  CAS  Google Scholar 

  24. Welliver RC, Kaul TN, Sun M, Ogra PL (1984) Defective regulation of immune responses in respiratory syncytial virus infection. J Immunol 133:1925–1930

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Virology, University of Newcastle-upon-Tyne Medical School, Framlington Place, NE2 4HH, Newcastle-upon-Tyne, UK

    G. L. Toms

Authors
  1. G. L. Toms
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Toms, G.L. Respiratory syncytial virus: Virology, diagnosis, and vaccination. Lung 168 (Suppl 1), 388–395 (1990). https://doi.org/10.1007/BF02718156

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02718156

Key words

Search

Navigation